RENIBUS.COM: Keyword Density Checker

Total words: 1306 | 2-word phrases: 337 | 3-word phrases: 363 | 4-word phrases: 373

PAGE INFO

Title	Try to keep the title under 60 characters (48 characters) Renibus Therapeutics: Prevent. Protect. Improve.
Description	Try to keep the meta description between 50 - 160 characters (225 characters) Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients’ lives to prevent disease progression, improve outcomes and protect against organ damage in cardiorenal diseases.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	and events careers	4	1.10%
2	news and events	4	1.10%
3	about us our	4	1.10%
4	contact x company	3	0.83%
5	approach pipeline publications	3	0.83%
6	x company about	3	0.83%
7	careers contact us	3	0.83%
8	patients news and	3	0.83%
9	pipeline publications patients	3	0.83%
10	events careers contact	3	0.83%
11	us our approach	3	0.83%
12	our approach pipeline	2	0.55%
13	on rbt1 at	2	0.55%
14	homepage prev next	2	0.55%
15	cardio renal and	2	0.55%
16	hydrochloric acid binder	2	0.55%
17	2024 renibus announces	2	0.55%
18	slide contact x	2	0.55%
19	news renibus therapeutics	2	0.55%
20	publications patients news	2	0.55%
21	search for about	2	0.55%
22	for about us	2	0.55%
23	a hydrochloric acid	1	0.28%
24	acid binder within	1	0.28%
25	of action as	1	0.28%
26	in treating orphan	1	0.28%
27	the gastrointestinal tract	1	0.28%
28	action as a	1	0.28%
29	gastrointestinal tract may	1	0.28%
30	as a hydrochloric	1	0.28%

#	Keyword	Frequency	Density
1	news and events careers	4	1.07%
2	contact x company about	3	0.80%
3	events careers contact us	3	0.80%
4	and events careers contact	3	0.80%
5	patients news and events	3	0.80%
6	about us our approach	3	0.80%
7	approach pipeline publications patients	2	0.54%
8	publications patients news and	2	0.54%
9	pipeline publications patients news	2	0.54%
10	slide contact x company	2	0.54%
11	our approach pipeline publications	2	0.54%
12	for about us our	2	0.54%
13	search for about us	2	0.54%
14	us our approach pipeline	2	0.54%
15	we are targeting several	1	0.27%
16	of action as a	1	0.27%
17	mechanism of action as	1	0.27%
18	veverimer’s mechanism of action	1	0.27%
19	targeting several indications where	1	0.27%
20	an oral nonabsorbed hydrochloric	1	0.27%
21	are targeting several indications	1	0.27%
22	from tricida we are	1	0.27%
23	tricida we are targeting	1	0.27%
24	acquired from tricida we	1	0.27%
25	acid binder that was	1	0.27%
26	oral nonabsorbed hydrochloric acid	1	0.27%
27	nonabsorbed hydrochloric acid binder	1	0.27%
28	as a hydrochloric acid	1	0.27%
29	hydrochloric acid binder that	1	0.27%
30	action as a hydrochloric	1	0.27%
31	skip to content renibus	1	0.27%
32	a hydrochloric acid binder	1	0.27%
33	unmet medical need renibus	1	0.27%
34	earlier stages of development	1	0.27%
35	at earlier stages of	1	0.27%
36	assets at earlier stages	1	0.27%
37	renibus has three additional	1	0.27%
38	need renibus has three	1	0.27%
39	medical need renibus has	1	0.27%
40	an unmet medical need	1	0.27%

#	URL	Whois	Check
1	https://twitter.com/Renibusinc	Whois	twitter.com
2	https://www.linkedin.com/company/renibus-therapeutics-inc/	Whois	linkedin.com